- Research works
- 58 ▲ 15% vs 2013–17
- Citations
- 401 6.9 per fractional work
- Top-10% rate
- 9.9% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Sun Pharma (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 19.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 19.8×
- Dentistry 10.1×
- Chemistry 4.5×
- Medicine 2.9×
- Nursing 2.2×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Health Professions 1.1×
- Immunology and Microbiology 1.0×
- Mathematics 0.9×
- Neuroscience 0.9×
- Materials Science 0.9×
- Agricultural and Biological Sciences 0.5×
- Psychology 0.5×
- Computer Science 0.4×
- Economics, Econometrics and Finance 0.3×
- Engineering 0.1×
Which keywords describe research at Sun Pharma (India)?
By fractional works in all years, weighted toward what it does more of than the world: Pharmacokinetics, Adverse Drug Reactions, Antioxidant, Clinical Trials, Cancer Therapy, Medicinal Chemistry, Metabolic Syndrome and Antioxidant Activity.
- Immunogenicity
- Signal Detection
- Optic Nerve
- Method Validation
- Cardiovascular Risk
- Solid Dispersions
- Glaucoma
- Drug Development Costs
- Cyclodextrins
- Insulin Resistance
- Virtual Screening
- Neuroprotective
- Pediatric Pharmacokinetics
- Drug Development
- Medicinal Chemistry
- Cancer Therapy
- Nanoparticles
- Clinical Trials
- Antioxidant
- Adverse Drug Reactions
- Pharmacokinetics
- Inflammation
- Epidemiology
- Metabolic Syndrome
- Cancer
- Cardiovascular Disease
- Antioxidant Activity
- Off-Label Drug Use
- Molecular Docking
- Drug Target Identification
- Biomarkers
- Drug Delivery
- Diabetes
- Generic Drugs
- Nutritional Value
- Type 2 Diabetes
- Clinical Guidelines
- Drug Discovery
- Pharmacovigilance
- Biological Activities
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Pharmacokinetics4▲ 25×7 topics
- Adverse Drug Reactions4▲ 102×2 topics
- Inflammation4▲ 2.8×23 topics
- Antioxidant4▲ 9.3×14 topics
- Epidemiology4▲ 1.59×23 topics
- Clinical Trials4▲ 9.6×5 topics
- Metabolic Syndrome3▲ 5.8×11 topics
- Nanoparticles3▲ 3.8×8 topics
- Cancer3▲ 3.2×13 topics
- Cancer Therapy3▲ 7.4×7 topics
- Cardiovascular Disease3▲ 3.9×12 topics
- Medicinal Chemistry3▲ 12×4 topics
- Antioxidant Activity2▲ 8.0×5 topics
- Drug Development2▲ 30×2 topics
- Off-Label Drug Use2▲ 111×1 topic
- Pediatric Pharmacokinetics2▲ 111×1 topic
- Molecular Docking2▲ 25×2 topics
- Neuroprotective2▲ 30×6 topics
- Drug Target Identification2▲ 48×1 topic
- Virtual Screening2▲ 48×1 topic
- Biomarkers2▲ 5.3×4 topics
- Insulin Resistance2▲ 7.0×5 topics
- Drug Delivery2▲ 6.5×4 topics
- Cyclodextrins2▲ 128×1 topic
- Diabetes2▲ 5.7×6 topics
- Drug Development Costs2▲ 113×1 topic
- Generic Drugs2▲ 113×1 topic
- Glaucoma2▲ 18×3 topics
- Nutritional Value2▲ 29×2 topics
- Solid Dispersions2▲ 128×1 topic
- Type 2 Diabetes2▲ 16×3 topics
- Cardiovascular Risk2▲ 7.9×5 topics
- Clinical Guidelines2▲ 8.7×4 topics
- Method Validation2▲ 35×2 topics
- Drug Discovery2▲ 6.4×5 topics
- Optic Nerve2▲ 26×2 topics
- Pharmacovigilance2▲ 205×1 topic
- Signal Detection2▲ 205×1 topic
- Biological Activities1▲ 13×2 topics
- Immunogenicity1▲ 47×3 topics
Which research topics does Sun Pharma (India) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Computational Drug Discovery Methods and Drug Solubulity and Delivery Systems.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 2 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 3 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 4 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
- 5 Oral microbiology and periodontitis research Periodontics 0 works
- 6 Epilepsy research and treatment Psychiatry and Mental health 0 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 8 Pharmacology and Obesity Treatment Pharmacology 0 works
- 9 Crystallization and Solubility Studies Materials Chemistry 0 works
- 10 Diverse Scientific Research Studies General Health Professions 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sun Pharma (India)'s research output changed?
Output in 2018–2022 was 15% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.